{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T16:10:51Z","timestamp":1691943051834},"reference-count":15,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SJU"],"abstract":"<jats:p>Editorial comment to Urosymphyseal fistula after pelvic radiotherapy \u2013 an entity in patients with significant comorbidity requiring multidisciplinary management Scand J Urol. 2023<\/jats:p>","DOI":"10.2340\/sju.v58.13470","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T06:22:41Z","timestamp":1691475761000},"page":"30-31","source":"Crossref","is-referenced-by-count":0,"title":["Long-term patient follow-up should be routinely implemented in radiotherapy units to detect late adverse effects after cancer treatment"],"prefix":"10.2340","volume":"58","author":[{"given":"Kirsti","family":"Aas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"35944","doi-asserted-by":"crossref","unstructured":"Moschini M, Zaffuto E, Karakiewicz PI, et al. External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: A population-based analysis. Eur Urol. 2019;75(2):319\u201328. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.034","DOI":"10.1016\/j.eururo.2018.09.034"},{"key":"35945","doi-asserted-by":"crossref","unstructured":"Guo X, Liu M, Hou H, et al. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer. Int J Clin Oncol. 2019;24(8):957\u201365. https:\/\/doi.org\/10.1007\/s10147-019-01427-9","DOI":"10.1007\/s10147-019-01427-9"},{"key":"35946","doi-asserted-by":"crossref","unstructured":"Zhao S, Xie Q, Yang R, et al. High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis. Cancer Manag Res. 2019;11:587\u201398. https:\/\/doi.org\/10.2147\/CMAR.S185867","DOI":"10.2147\/CMAR.S185867"},{"key":"35947","doi-asserted-by":"crossref","unstructured":"Martin SE, Begun EM, Samir E, Azaiza MT, Allegro S, Abdelhady M. Incidence and morbidity of radiation-induced hemorrhagic cystitis in prostate cancer. Urology. 2019;131:190\u20135. https:\/\/doi.org\/10.1016\/j.urology.2019.05.034","DOI":"10.1016\/j.urology.2019.05.034"},{"key":"35948","doi-asserted-by":"crossref","unstructured":"Makino K, Sato Y, Takenaka R, et al. Cumulative incidence and clinical risk factors of radiation cystitis after radiotherapy for prostate cancer. Urol Int. 2023;107(5):440\u2013447. https:\/\/doi.org\/10.1159\/000521723","DOI":"10.1159\/000521723"},{"key":"35949","doi-asserted-by":"crossref","unstructured":"Carlsson S, Bock D, Lantz A, et al. Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up. Scand J Urol. 2023;58:11\u20139. https:\/\/doi.org\/10.2340\/sju.v58.7318","DOI":"10.2340\/sju.v58.7318"},{"key":"35950","doi-asserted-by":"crossref","unstructured":"Braide K, Kindblom J, Thellenberg Karlsson C, Stattin P, Hugosson J, Mansson M. Risk of severe late toxicity after radiotherapy following radical prostatectomy \u2013 a nationwide study. BJU Int. 2022;130(6):799\u2013808. https:\/\/doi.org\/10.1111\/bju.15769","DOI":"10.1111\/bju.15769"},{"key":"35951","doi-asserted-by":"crossref","unstructured":"Fridriksson JO, Folkvaljon Y, Nilsson P, et al. Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study. Scand J Urol. 2016;50(5):\u200b338\u201345. https:\/\/doi.org\/10.1080\/21681805.2016.1194460","DOI":"10.1080\/21681805.2016.1194460"},{"key":"35952","doi-asserted-by":"crossref","unstructured":"David RV, Kahokehr AA, Lee J, Watson DI, Leung J, O\u2019Callaghan ME. Incidence of genitourinary complications following radiation therapy for localised prostate cancer. World J Urol. 2022;40(10):2411\u201322. https:\/\/doi.org\/10.1007\/s00345-022-04124-x","DOI":"10.1007\/s00345-022-04124-x"},{"key":"35953","doi-asserted-by":"crossref","unstructured":"Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047\u201360. https:\/\/doi.org\/10.1016\/S1470-2045(16)30102-4","DOI":"10.1016\/S1470-2045(16)30102-4"},{"key":"35954","doi-asserted-by":"crossref","unstructured":"Lane JA, Donovan JL, Young GJ, et al. Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU Int. 2022;130(3):\u200b370\u201380. https:\/\/doi.org\/10.1111\/bju.15739","DOI":"10.1111\/bju.15739"},{"key":"35955","doi-asserted-by":"crossref","unstructured":"Yu T, Zhang Q, Zheng T, et al. The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: a meta-analysis of the literatures. PLoS One. 2016;11(5):e0154499. https:\/\/doi.org\/10.1371\/journal.pone.0154499","DOI":"10.1371\/journal.pone.0154499"},{"key":"35956","doi-asserted-by":"crossref","unstructured":"Kerkmeijer LGW, Groen VH, Pos FJ, et al. Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial. J Clin Oncol. 2021;39(7):787\u201396. https:\/\/doi.org\/10.1200\/JCO.20.02873","DOI":"10.1200\/JCO.20.02873"},{"key":"35957","doi-asserted-by":"crossref","unstructured":"Hamstra DA, Stenmark MH, Ritter T, et al. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2013;85(5):1246\u201353. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.10.042","DOI":"10.1016\/j.ijrobp.2012.10.042"},{"key":"35958","doi-asserted-by":"crossref","unstructured":"David R, Hiwase M, Kahokehr AA, et al. Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer. World J Urol. 2022;40(12):2911\u20138. https:\/\/doi.org\/10.1007\/s00345-022-04212-y","DOI":"10.1007\/s00345-022-04212-y"}],"container-title":["Scandinavian Journal of Urology"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/download\/13470\/22192","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/download\/13470\/22216","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/download\/13470\/22217","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/download\/13470\/22192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T15:33:51Z","timestamp":1691940831000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/view\/13470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.2340\/sju.v58.13470","relation":{},"ISSN":["2168-1813","2168-1805"],"issn-type":[{"value":"2168-1813","type":"electronic"},{"value":"2168-1805","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,7]]}}}